Clinical trial NCT06201299: Chair-based and Standard Exercise Programs in People With COPD
Official title: Comparison of the Effectiveness of Chair-based and Standard Exercise Programs in People With COPD
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: COPD
Pulmonary Rehabilitation
Exercise
Lead sponsor: Istanbul Medipol University Hospital
Sponsor class: OTHER
First posted: 2024-01-11
Enrollment: 64
Sex: ALL
Minimum age (years): 18
Maximum age (years): 75
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Patients who are diagnosed with COPD by a pulmonology specialist and referred to pulmonary rehabilitation will be included in the study. Cases that meet the inclusion criteria will be randomized and divided into two groups, standard exercise program group (SGr) and chair-based exercise. program group will be called (ChGr). While standard exercises will be given to SGr, chair-based exercises will be applied to ChGr. All evaluation and initial training sessions of the cases will be held in the hospital. Apart from this, they will be asked to do their exercises at home with the exercise videos that will be sent to them. In order to ensure that home exercises are performed completely and correctly, 2 sessions of online simultaneous exercise training will be provided with a physiotherapist via videoconference on a smartphone, and exercise follow-ups will be carried out by calling once a week. The program duration is 8 weeks, 5 days a week.


Eligibility criteria: Inclusion Criteria:

* Being between the ages of 18-75 years
* Having a diagnosis of COPD diagnosed according to clinical diagnostic criteria according to the American Thoracic and European Respiratory Societies (ATS-ERS).
* Presence of dyspnea on exertion
* Stable clinical status at inclusion without infection or exacerbation in the previous 4 weeks \*Having smart phone usage skills

Exclusion Criteria:

* Patients with severe comorbid diseases, unstable coronary artery disease, collagen vascular diseases and requiring high-flow oxygen therapy (˃ 3-4 L\\min).
* A history of exertional syncope or the presence of any comorbidities (such as severe orthopedic or neurological deficits or unstable heart disease) that preclude exercise training.
* Having participated in a pulmonary rehabilitation program within the last 12 months.

Primary outcomes:
measure: Exercise capacity assesment
timeFrame: Change from baseline at 2 months
Secondary outcomes:
measure: Dyspnea evaluation
timeFrame: Change from baseline at 2 months
measure: Respiratory muscle strength measurement
timeFrame: Change from baseline at 2 months
measure: Peripheral muscle strength measurement
timeFrame: Change from baseline at 2 months
measure: Evaluation of quality of life
timeFrame: Change from baseline at 2 months
measure: Evaluation of fatigue
timeFrame: Change from baseline at 2 months
measure: Psychological status assessment
timeFrame: Change from baseline at 2 months
measure: Physical activity level assesment
timeFrame: Change from baseline at 2 months
measure: Pulmonary function tests (PFTs)
timeFrame: Change from baseline at 2 months
Other outcomes:
Locations:
city: Istanbul
country: Turkey
facility: Yedikule Chest Disease Hospital
state: Zeytinburnu
Study officials:
References: